Headliner

Back at Dendreon, Caggiano takes on Provenge's comeback

Back at Dendreon, Caggiano takes on Provenge's comeback

By

Jim Caggiano had witnessed Provenge's birth during an earlier turn at Dendreon and couldn't understand what went wrong.

J&J's Joaquin Duato: Diversity is 'essential'

J&J's Joaquin Duato: Diversity is 'essential'

Under Duato, the leadership team for Johnson & Johnson's pharma group includes six women. "We don't just talk about it," he says.

Why Philips' Erik Hollander turned to reinvention

Why Philips' Erik Hollander turned to reinvention

By

He describes his current charge as "transforming a more creative occupation into a science."

If CSL Limited CEO Paul Perreault sneezes, Australia gets a cold

If CSL Limited CEO Paul Perreault sneezes, Australia gets a cold

By

"In Australia, we are the healthcare industry," he says.

Bolstered by new data, Radius Health focuses on unmet needs in the osteoporosis market

Bolstered by new data, Radius Health focuses on unmet needs in the osteoporosis market

By

Only one new osteoporosis drug has been approved over the last six years.

Avanir marketing chief on selling first-in-class therapies

Avanir marketing chief on selling first-in-class therapies

By

Avanir's success with Nuedexta sparked the attention of several suitors. In 2014 the company reached a deal to be sold to Otsuka Pharmaceutical for around $3.5 billion

Be a better mentor, says Baxalta's Leonardi

Be a better mentor, says Baxalta's Leonardi

By

Too often left undiscussed is that a powerful business case can be made for more frequent and focused mentorship.

Second-generation IBM star pushes for partnerships

Second-generation IBM star pushes for partnerships

By

With a lead role in IBM Watson's bold gambit to transform healthcare, Kathy McGroddy-Goetz ranks as one of the enterprise's most important individuals.

How My GI Health changed the conversation for patients

How My GI Health changed the conversation for patients

By

The motivating force behind My GI Health met initial resistance. After all, it came from a company executive who professed that his goal was to benefit all companies within that therapeutic area.

Ironwood's McCourt bets big on data and the patient-physician dialogue

Ironwood's McCourt bets big on data and the patient-physician dialogue

By

Tom McCourt says he's "a marketing guy who hopefully understands a little about drug development" even as he guided drugs like Prilosec to market.

TMC's McGuire preps CRE antibiotic for market

TMC's McGuire preps CRE antibiotic for market

By

The Medicines Company's commercial lead for infection disease care talks about its breakthrough antidote for carbapenem-resistant enterobacteriaceae.

Medicines360 CEO battles for IUD access

Medicines360 CEO battles for IUD access

By

Prior to Medicines360's arrival on the scene, there were only three IUDs on the market. The lack of competition drove prices sky-high.

Baxalta's oncology chief builds out company's third leg

Baxalta's oncology chief builds out company's third leg

By

David Meek has been charged with building an oncology arm that matches the company's existing strengths in hematology and immunology.

Headliner: Weill Cornell Dean/Doc Gets High Marks

Headliner: Weill Cornell Dean/Doc Gets High Marks

By

"Partnering up in complete transparency is the best possible scenario for patients"

Headliner: Spark CCO maps gene therapy vision

Headliner: Spark CCO maps gene therapy vision

"Gene therapy is a collection of small details. It's not a secret sauce."

Headliner: Alcon ace pilots lens work with Google

Headliner: Alcon ace pilots lens work with Google

By

Alcon ace pilots lens work with Google

Headliner: Sales vet keeps 111-year-old title spry

Headliner: Sales vet keeps 111-year-old title spry

By

Amy Clarke Luchsinger "thinks that HCPs want both digital and print. The people [she] talks with just want to be able to access information when and where they want it . . .

Headliner: Silk smooths Takeda myeloma shift

Headliner: Silk smooths Takeda myeloma shift

By

He didn't want to just invest in a winning horse—he wanted to help groom it

Novo Nordisk executive fuels firm's new obesity fight

Novo Nordisk executive fuels firm's new obesity fight

By

"An epidemic comes and goes. This is a trend curve. We need to bend that curve."

Headliner: Pfizer's mentoring maestro hones his craft

Headliner: Pfizer's mentoring maestro hones his craft

By

The Healthcare Businesswoman's Association 2015 Honorable Mentor has elevated mentoring to a prominent place.

Headliner: Dexcom device executive presses connectivity

Headliner: Dexcom device executive presses connectivity

By

"Some people wake up in the middle of the night worrying about business," Kevin Sayer says. But when he wakes up he can't sleep because he's so excited!

Headliner: New Synta chief adds commercialization clout

Headliner: New Synta chief adds commercialization clout

By

Anne Whitaker, President and CEO, Synta Pharmaceuticals

Headliner: Scientist CEO sets sights on Sierra Leone

Headliner: Scientist CEO sets sights on Sierra Leone

By

Thomas Sack, President and CEO, MRIGlobal

Purdue CCO makes a drive for diversity

Purdue CCO makes a drive for diversity

By

Adding skills diversity to Purdue's talent base is an important goal

Headliner: Pharma vet charts consultancy course

Headliner: Pharma vet charts consultancy course

By

Dennis Urbaniak, managing director, Accenture Life Sciences

Headliner: HealthSpot's teleconnected CEO

Headliner: HealthSpot's teleconnected CEO

By

Steve Cashman, Founder and CEO, HealthSpot